282 related articles for article (PubMed ID: 23580344)
21. Metabolic syndrome and heart failure--the risk, paradox, and treatment.
Gaddam KK; Ventura HO; Lavie CJ
Curr Hypertens Rep; 2011 Apr; 13(2):142-8. PubMed ID: 21298579
[TBL] [Abstract][Full Text] [Related]
22. Evaluating obesity and cardiovascular risk factors in children and adolescents.
Spiotta RT; Luma GB
Am Fam Physician; 2008 Nov; 78(9):1052-8. PubMed ID: 19007051
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive assessment of target organ injury in children with the metabolic syndrome.
Urbina E
J Cardiometab Syndr; 2006; 1(4):277-81. PubMed ID: 17679807
[TBL] [Abstract][Full Text] [Related]
24. Dyslipidaemia, hypercoagulability and the metabolic syndrome.
Kakafika AI; Liberopoulos EN; Karagiannis A; Athyros VG; Mikhailidis DP
Curr Vasc Pharmacol; 2006 Jul; 4(3):175-83. PubMed ID: 16842135
[TBL] [Abstract][Full Text] [Related]
25. Dyslipidemia and pediatric obesity.
Cook S; Kavey RE
Pediatr Clin North Am; 2011 Dec; 58(6):1363-73, ix. PubMed ID: 22093856
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index.
Redondo MJ; Foster NC; Libman IM; Mehta SN; Hathway JM; Bethin KE; Nathan BM; Ecker MA; Shah AC; DuBose SN; Tamborlane WV; Hoffman RP; Wong JC; Maahs DM; Beck RW; DiMeglio LA
Acta Diabetol; 2016 Apr; 53(2):271-7. PubMed ID: 26077171
[TBL] [Abstract][Full Text] [Related]
27. Bariatric Surgery as a Long-Term Treatment for Type 2 Diabetes/Metabolic Syndrome.
Hanipah ZN; Schauer PR
Annu Rev Med; 2020 Jan; 71():1-15. PubMed ID: 31986081
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome in young people.
Poyrazoglu S; Bas F; Darendeliler F
Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
[TBL] [Abstract][Full Text] [Related]
29. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
[TBL] [Abstract][Full Text] [Related]
30. [Hypertension, dyslipoproteinemia and BMI-category characterise the cardiovascular risk in overweight or obese children and adolescents: data of the BZgA-observational study (EvAKu-J-project) and the KiGGS-study].
Flechtner-Mors M; Thamm M; Rosario AS; Goldapp C; Hoffmeister U; Mann R; Bullinger M; van Egmond-Fröhlich A; Ravens-Sieberer U; Reinehr T; Westenhöfer J; Holl RW
Klin Padiatr; 2011 Dec; 223(7):445-9. PubMed ID: 22012610
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome in obese Thai children and adolescents.
Iamopas O; Chongviriyaphan N; Suthutvoravut U
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded "Double-Trouble" Lipid Profile in Overweight/Obese.
Spannella F; Giulietti F; Di Pentima C; Sarzani R
Adv Ther; 2019 Jun; 36(6):1426-1437. PubMed ID: 30953331
[TBL] [Abstract][Full Text] [Related]
33. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
[TBL] [Abstract][Full Text] [Related]
34. Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents.
Kennedy MJ; Jellerson KD; Snow MZ; Zacchetti ML
Paediatr Drugs; 2013 Oct; 15(5):335-42. PubMed ID: 23677836
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children.
Casavalle PL; Lifshitz F; Romano LS; Pandolfo M; Caamaño A; Boyer PM; Rodríguez PN; Friedman SM
Pediatr Endocrinol Rev; 2014 Dec; 12(2):213-23. PubMed ID: 25581987
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of overweight/obesity and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome: a survey in the suburban area of Beijing, 2007.
Zhang L; Zhang WH; Zhang L; Wang PY
Obes Facts; 2011; 4(4):284-9. PubMed ID: 21921651
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome update.
Grundy SM
Trends Cardiovasc Med; 2016 May; 26(4):364-73. PubMed ID: 26654259
[TBL] [Abstract][Full Text] [Related]
38. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
l'Allemand-Jander D
Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
[TBL] [Abstract][Full Text] [Related]
39. Laboratory assessment of cardiometabolic risk in overweight and obese children.
Sypniewska G
Clin Biochem; 2015 Apr; 48(6):370-6. PubMed ID: 25583095
[TBL] [Abstract][Full Text] [Related]
40. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
Jialal I; Smith G
Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
